Press Releases
Jan. 28, 2026
BCC Research Reports Highlight Markets Exceeding 25%+ CAGR
Indeterminate
GlobeNewswire, Inc.
Feb. 4, 2026
HMP Global Launches Clinical Pathways NEXT to Address Real-Time Oncology Pathway Decision-Making
Neutral
EIN Presswire
Feb. 4, 2026
Kymera Therapeutics to Participate in Upcoming February Investor Conferences
Indeterminate
GlobeNewswire, Inc.
Jan. 28, 2026
Ataccama Named a Leader in Data Quality Solutions Report by Independent Research Firm
Indeterminate
GlobeNewswire, Inc.
Jan. 28, 2026
Matlantis Launches Matlantis CSP, a New Capability to Rapidly Discover Unknown Stable Crystal Structures
Indeterminate
GlobeNewswire, Inc.
Jan. 28, 2026
Powering the Future: Gas and Steam Turbine Market on the Rise
Indeterminate
GlobeNewswire, Inc.
Jan. 26, 2026
The Human Counter-Revolution: KissFromItaly Expands Amalfi Fleet to Defy the 'Cold' AI Travel Trend
Neutral
EIN Presswire
Jan. 28, 2026
HealthEdge® and Suki Introduce Ambient Clinical Intelligence for Care Management
Indeterminate
GlobeNewswire, Inc.
Jan. 28, 2026
Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies
Indeterminate
GlobeNewswire, Inc.
Jan. 26, 2026
GAI Insights Airs 500th Episode of Daily AI News
Neutral
EIN Presswire
Jan. 27, 2026
Acoustic Launches Native Integrations with Leading Commerce Platforms
Indeterminate
GlobeNewswire, Inc.
Jan. 27, 2026
AI in Food Retail and e-Commerce to Grow 30.8% Annually Through 2030
Indeterminate
GlobeNewswire, Inc.
Jan. 27, 2026
Imviva Biotech Receives FDA Orphan Drug Designation for CTD402 for the Treatment of T-Cell Leukemia and Lymphoma
Indeterminate
GlobeNewswire, Inc.
Jan. 26, 2026
DraftKings to Release Fourth Quarter 2025 Results on February 12, 2026 and Host Investor Day on March 2, 2026
Indeterminate
GlobeNewswire, Inc.